Quick Answer
LifeStance Health Group, Inc. reported Long Term Debt of $265.93 million for the year ending 2025.
- LifeStance Health Group, Inc. showed a decrease of -5.0% in Long Term Debt from 2024 to 2025.
- This data is from LifeStance Health Group, Inc.'s annual report (Form 10-K), filed with the SEC on February 25, 2026.
- XBRL data for this metric is available from 2020 to 2025 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2021: $157.07 million | Q3 2021: $157.45 million | Q1 2022: $177.38 million | Q2 2022: $203.36 million | Q3 2022: $212.04 million | Q1 2023: $224.76 million | Q2 2023: $248.72 million | Q3 2023: $248.37 million | Q1 2024: $279.87 million | Q2 2024: $279.46 million | Q3 2024: $279.06 million | Q1 2025: $276.32 million | Q2 2025: $272.86 million | Q3 2025: $269.39 million.
- Over the full 6 years of available data (2020 to 2025), LifeStance Health Group, Inc.'s Long Term Debt has declined by 26.6%.
- Historical annual values: Fiscal year 2025: $265.93 million | Fiscal year 2024: $279.79 million | Fiscal year 2023: $280.29 million | Fiscal year 2022: $225.08 million | Fiscal year 2021: $157.42 million | Fiscal year 2020: $362.53 million.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: